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1. INTRODUCTION {#jmd212123-sec-0001}
===============

Niemann Pick disease type C (NPC), Gaucher disease and lysosomal acid lipase deficiency are well‐known metabolic causes of severe liver disease and macrophage activation in infancy. Although rare, the classic hepatic subtype of glycogen storage disorder type IV(GSD IV) is characterised by early‐onset liver disease and is unique in that liver transplantation has a favourable outcome in these patients. There are very few case reports of raised chitotriosidase activity in GSD IV.[1](#jmd212123-bib-0001){ref-type="ref"}, [2](#jmd212123-bib-0002){ref-type="ref"} We report a 13‐month‐old boy with GSDIV who presented with early‐onset chronic liver disease and raised chitotriosidase but was critically ill when listed for liver transplantation and sadly succumbed to fulminant hepatic failure.

###### SYNOPSIS

To consider GSD IV as a possible cause of acute on chronic liver disease with raised chitotriosidase as liver transplantation has a beneficial role in altering the outcome of those with mainly hepatic manifestations of this condition.

2. CASE PRESENTATION {#jmd212123-sec-0002}
====================

This boy was born at term to non‐consanguineous Caucasian parents after an uneventful pregnancy. Developmental history was unremarkable. He was noted to have a distended abdomen at 6 months of age and was referred to secondary care at the age of 11 months in view of worsening abdominal distension, jaundice and lethargy following varicella zoster infection. On examination, he had icterus and mild respiratory distress. His abdomen was distended with dilated abdominal veins; liver was enlarged at 7 cm and the spleen 10 cm down the costal margin. He was found to have ascites, conjugated hyperbilirubinemia and synthetic hepatic dysfunction with coagulopathy and hypoalbuminemia. Serum bilirubin was 104 μmol/L(0‐18) with a direct component of 91 μmol/L (0‐11). Alkaline phosphatase was 1246 IU/L(90‐290), alanine transaminase and aspartate aminotransferase were 217 IU/L (0‐50) and 609 IU/L (0‐50), respectively. Clotting was deranged with a prothrombin time of 28 seconds (9‐13), APTT of 37 seconds (24‐32) and fibrinogen of 0.8 (1.5‐4.5). Albumin was 33 g/L (43‐54). He had thrombocytopenia with a platelet count of 90 (150‐400).

Renal tubular reabsorption of phosphate was normal. Urine organic acids showed raised 4‐hydroxyphenyl pyruvate and 4‐hydroxyphenyl lactate consistent with liver dysfunction. Galactosemia, tyrosinemia and mitochondrial DNA depletion screen were unremarkable. Serum chitotriosidase was elevated at 28.00 μmol/min/L (0.1‐2.5). White cell enzyme assay for Gaucher, Niemann Pick A and B and lysosomal acid lipase deficiency were all within normal limits. Bone marrow aspirate showed no evidence of infiltration.

Ultrasound scan of the abdomen showed dampened flow to hepatic veins and CT angiogram of the abdomen demonstrated a thrombus in portal vein and narrowing of hepatic veins raising the possibility of Budd‐Chiari syndrome.

NPC was considered as the provisional diagnosis in view of the clinical picture and raised serum chitotriosidase, despite the normal bone marrow biopsy. Mutation analysis was scheduled, but at the time turnaround was slow. Consideration of liver transplantation and hepatic venography with transjugular liver biopsy was postponed until he recovered from varicella zoster. Echocardiography was normal and did not show any evidence of cardiomyopathy.

2.1. Progress {#jmd212123-sec-0003}
-------------

One month later he was electively admitted for assessment and management of his liver disease. A transjugular liver biopsy and hepatic venogram were performed following which he developed respiratory distress requiring intensive care management. He developed pulmonary haemorrhage and was on high‐frequency oscillatory ventilation (HFOV). Sequence analysis of NPC 1 and 2 genes did not reveal any mutations. The liver biopsy had classical changes of GSD IV (Figure [1](#jmd212123-fig-0001){ref-type="fig"}). He was considered for liver transplantation but was too unwell due to pulmonary haemorrhage which proved fatal. Subsequent to his death, mutational analysis of the GBE 1 gene showed that he was compound heterozygous for the p.(Arg515His), c. 1544G \> A mutation and the p.(Arg524\*), c.1570C \> T mutation in exon 12 of the gene, confirming the diagnosis of GSDIV. These mutations have been previously reported to be pathogenic.[^4^](#jmd212123-bib-0004){ref-type="ref"}

![Liver biopsy shows abundant in part very large non‐membrane bound inclusions composed of fine fibrillary material admixed with more coarse glycogen. Membrane bound similar appearing inclusions are seen in macrophages. These appearances further support a diagnosis of GSD type 4. In contrast to other forms of glycogen storage disease, the hepatocytes do not show cytoplasmic clearing. The background image (original magnification ×400, haematoxylin and eosin) shows ill‐defined pale inclusions within the cells (examples within rectangles). Staining with periodic acid Schiff (PAS), bottom left panel, highlights the inclusions and these are resistant to diastase (PASD bottom right, example arrowed)](JMD2-54-22-g001){#jmd212123-fig-0001}

3. DISCUSSION {#jmd212123-sec-0004}
=============

The classic hepatic form of GSD IV rapidly progresses to cirrhosis in the first 18 months of life and results in end‐stage liver disease with death due to liver failure between 3 and 5 years of age. Our patient had features of hepatic GSD IV with accelerated disease progression probably secondary to varicella zoster infection. He presented at 11 months of age with acute on chronic liver failure which rapidly progressed, leading to death at 13 months of age. He did not have a liver biopsy at presentation due to varicella zoster infection and the elevated chitotriosidase raised the suspicion of NPC disease which was important to exclude as LT is usually contraindicated. Liver transplantation was deferred until the results of mutational analysis of NPC gene (usually available after 12 weeks) were available. Current practice with more rapid turnaround of genetic analysis would have allowed both earlier confirmation of the true diagnosis and exclusion of NPC.

Hizarcioglu‐Gulsen et al reported a similar case of GSD IV who in contrast to our case presented at the age of 3.5 years in mild acute liver failure and in whom an early liver biopsy led to the diagnosis.[^1^](#jmd212123-bib-0001){ref-type="ref"} She was also noted to have elevated plasma chitotriosidase of 1209 nmol/h/mL (reference range: 0‐90 nmol/h/mL) and two foamy cells on bone marrow aspiration. Raised chitotriosidase is a non‐specific marker and is often seen in chronic liver diseases with macrophage activation. There are two previous reports of children with glycogen storage disease (GSD) type IV who were found to have high chitotriosidase levels.[1](#jmd212123-bib-0001){ref-type="ref"}, [2](#jmd212123-bib-0002){ref-type="ref"}GSD type IV although very rare, should be considered as a possible differential when a child presents with stigmata of chronic liver disease and raised chitotriosidase. Liver transplantation has a beneficial role and halts the disease progression particularly in those with mainly hepatic manifestations as compared to those with extrahepatic manifestations prior to transplant.[^3^](#jmd212123-bib-0003){ref-type="ref"} Our patient had purely hepatic involvement in terms of rapidly progressive liver failure and therefore would have fit the criteria for liver transplantation had the diagnosis been made early.
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